Fetal Erythroblastosis

The fetal erythroblastosis is a hemolytic anemia of fetuses (or newborn as erythroblastosis neonatorum), which is caused by a transplacental crossing maternal antibodies to fetal erythrocytes. The disease usually results from an incompatibility between maternal and fetal blood type, often Rh0 (D) antigens. The diagnostic begins with a prenatal maternal antigen-antibody screening, and may also require a paternal screening, a repeated measurement of the maternal antibody titer and an examination…

September 3, 2018